Please use this identifier to cite or link to this item:
http://dspace.hmtu.edu.vn/handle/DHKTYTHD_123/2869Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Grimwade, David | - |
| dc.contributor.author | D. Freeman, Sylvie | - |
| dc.date.accessioned | 2019-02-18T03:18:36Z | - |
| dc.date.available | 2019-02-18T03:18:36Z | - |
| dc.date.issued | 2014 | - |
| dc.identifier.uri | http://dspace.hmtu.edu.vn/handle/DHKTYTHD_123/2869 | - |
| dc.description | Chính văn tài liệu | vi |
| dc.language.iso | en | vi |
| dc.publisher | American Society of Hematology | vi |
| dc.subject | Hematology | vi |
| dc.subject | acute myeloid leukemia | vi |
| dc.title | Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for “prime time”? | vi |
| dc.type | Article | vi |
| Appears in Collections | Huyết học | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Defining minimal residual disease in acute myeloid leukemia.pdf Restricted Access | 1.27 MB | Adobe PDF |  Request Item |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.